Usefulness of B-type natriuretic peptides to predict cardiovascular events in women (from the Women's Health Study)

American Journal of Cardiology

Volumn 116, Issue 4, 2015, Pages 532-537

  Everett, Brendan M ^a   Ridker, Paul M ^a   Cook, Nancy R ^a   Pradhan, Aruna D ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TROPONIN T; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CASE STUDY; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REYNOLDS RISK SCORE; WOMEN'S HEALTH; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; INCIDENCE; MIDDLE AGED; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE;

AGED; ANTIOXIDANTS; ASPIRIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; VITAMIN E;

EID: 84938216661     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.05.014     Document Type: Article

References (22)

1. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, and P.A. McCullough Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
2. J.L. Januzzi Jr., C.A. Camargo, S. Anwaruddin, A.L. Baggish, A.A. Chen, D.G. Krauser, R. Tung, R. Cameron, J.T. Nagurney, C.U. Chae, D.M. Lloyd-Jones, D.F. Brown, S. Foran-Melanson, P.M. Sluss, E. Lee-Lewandrowski, and K.B. Lewandrowski The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
3. K. Thygesen, J. Mair, C. Mueller, K. Huber, M. Weber, M. Plebani, Y. Hasin, L.M. Biasucci, E. Giannitsis, B. Lindahl, W. Koenig, M. Tubaro, P. Collinson, H. Katus, M. Galvani, P. Venge, J.S. Alpert, C. Hamm, and A.S. Jaffe Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Eur Heart J 33 2012 2001 2006
4. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, and R.S. Vasan Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
5. M.H. Olsen, T.W. Hansen, M.K. Christensen, F. Gustafsson, S. Rasmussen, K. Wachtell, H. Ibsen, C. Torp-Pedersen, and P.R. Hildebrandt N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur Heart J 28 2007 1374 1381
6. O. Melander, C. Newton-Cheh, P. Almgren, B. Hedblad, G. Berglund, G. Engstrom, M. Persson, J.G. Smith, M. Magnusson, A. Christensson, J. Struck, N.G. Morgenthaler, A. Bergmann, M.J. Pencina, and T.J. Wang Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 2009 49 57
7. T. Takahashi, M. Nakamura, T. Onoda, M. Ohsawa, K. Tanno, K. Itai, K. Sakata, M. Sakuma, F. Tanaka, S. Makita, Y. Yoshida, A. Ogawa, K. Kawamura, and A. Okayama Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study Atherosclerosis 207 2009 298 303
8. B. Zethelius, L. Berglund, J. Sundström, E. Ingelsson, S. Basu, A. Larsson, P. Venge, and J. Arnlöv Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
9. J.A. Laukkanen, S. Kurl, M. Ala-Kopsala, O. Vuolteenaho, H. Ruskoaho, K. Nyyssonen, and J.T. Salonen Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men Eur Heart J 27 2006 1230 1237
10. B.M. Everett, J.S. Berger, J.E. Manson, P.M. Ridker, and N.R. Cook B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women J Am Coll Cardiol 64 2014 1789 1797
11. S. Blankenberg, T. Zeller, O. Saarela, A.S. Havulinna, F. Kee, H. Tunstall-Pedoe, K. Kuulasmaa, J. Yarnell, R.B. Schnabel, P.S. Wild, T.F. Münzel, K.J. Lackner, L. Tiret, A. Evans, V. Salomaa Project M Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
12. B.M. Everett, N.R. Cook, M.C. Magnone, M. Bobadilla, E. Kim, N. Rifai, P.M. Ridker, and A.D. Pradhan Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study Circulation 123 2011 2811 2818
13. W.E. Barlow Robust variance estimation for the case-cohort design Biometrics 50 1994 1064 1072
14. B. Langholz, and J. Jiao Computational methods for case-cohort studies Comp Stats Data Anal 51 2007 3737 3748
15. T.M. Therneau, and H. Li Computing the Cox model for case cohort designs Lifetime Data Anal 5 1999 99 112
16. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, C.J. O'Donnell, S. Coady, J. Robinson, R.B. D'Agostino Sr., J.S. Schwartz, R. Gibbons, S.T. Shero, P. Greenland, S.C. Smith Jr., D.T. Lackland, P. Sorlie, D. Levy, N.J. Stone, and P.W. Wilson 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2013 2935 2959
17. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
18. C. Kistorp, I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults JAMA 293 2005 1609 1616
19. S. Sadanandan, C.P. Cannon, K. Chekuri, S.A. Murphy, P.M. Dibattiste, D.A. Morrow, J.A. de Lemos, E. Braunwald, and C.M. Gibson Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 564 568
20. C. Kragelund, B. Gronning, L. Kober, P. Hildebrandt, and R. Steffensen N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N Engl J Med 352 2005 666 675
21. K.K. Patton, P.T. Ellinor, S.R. Heckbert, R.H. Christenson, C. DeFilippi, J.S. Gottdiener, and R.A. Kronmal N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study Circulation 120 2009 1768 1774
22. A.R. Folsom, V. Nambi, E.J. Bell, O.W. Oluleye, R.F. Gottesman, P.L. Lutsey, R.R. Huxley, C.M. Ballantyne, and T. Troponin N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study Stroke 44 2013 961 967